P

    Prenetics Global Ltd (PRE)

    Official site

    CONSUMER DEFENSIVE • DIAGNOSTICS & RESEARCH • NASDAQ

    $26.25
    +0.49 (+1.90%)

    Market Cap: $432.24M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(9/18)
    Avg Surprise
    -158.51%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.51
    Range$-0.51 - $-0.51
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.42+17.6%
    60d ago$-0.42+17.6%
    30d ago$-0.42+17.6%
    7d ago$-0.42+17.6%
    Current$-0.51
    Revenue Consensus
    $63M
    Range$63M - $64M
    4 analysts
    Dec 31, 2026
    EPS Consensus$-1.11
    Range$-1.11 - $-1.11
    1 analysts
    Revenue Consensus
    $75M
    Range$72M - $76M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.11---
    Sep 26EST
    		-$-0.51---
    Jun 26
    		$-0.53$-0.32-65.63%Miss+43.6%
    Mar 26
    		$-0.56$-0.49-14.29%Miss+30.0%
    Dec 25
    		$-0.27$-0.49+44.90%Beat+79.1%
    Sep 25
    		$-0.53$-0.55+3.64%Beat+36.9%
    Jun 25
    		$-0.94$-0.71-32.39%Miss-6.8%
    Mar 25
    		$-0.80$-0.80+0.00%Beat+84.9%
    Dec 24
    		$-1.29$-0.72-79.17%Miss+17.8%
    Sep 24
    		$-0.84$-0.86+2.33%Beat+30.0%
    Jun 24
    		$-0.88$-0.93+5.38%Beat-780.0%
    Mar 24
    		$-5.30$-4.80-10.42%Miss-404.8%
    Dec 23
    		$-1.57$-0.05-3040.00%Miss-1146.7%
    Sep 23
    		$-1.20$-1.20+0.00%Beat-126.9%
    Jun 23
    		$-0.10$-0.05-100.00%Miss-350.0%
    Mar 23
    		$-1.05$-0.75-40.00%Miss+96.8%
    Dec 22
    		$0.15N/A+110.00%Beat+3.8%
    Sep 22
    		$4.46$-1.95+328.72%Beat+5055.6%
    Jun 22
    		$0.04N/A+106.45%Beat+130.8%
    Mar 22
    		$-33.15$-19.20-72.66%Miss-
    Dec 21
    		$0.14N/AN/ABeat-
    Sep 21
    		$-0.09N/AN/ABeat-
    Jun 21
    		$-0.13$0.00N/AMiss-
    Mar 21
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-13.89EV/EBITDA0.14x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-30.40%Operating Margin-45.10%
    ROE-47.00%ROIC-76.94%
    Financial Health
    Debt/Equity0.01xInterest Coverage-590.03x
    Current Ratio4.04xQuick Ratio3.66x
    Trading Statistics
    Beta0.25Avg Volume260.12K
    52-Week High$26.5052-Week Low$7.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.54
    SMA 20$20.70
    SMA 50$19.65
    SMA 200$18.16
    EMA 10$23.45
    EMA 20$21.77
    EMA 50$20.24
    EMA 200$17.60

    MACD

    Line: 1.73Signal: 0.92Hist: 0.81

    ADX

    ADX: 33.7+DI: 34.6-DI: 8.5

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down76.0
    PSAR$19.51

    Bollinger Bands

    Upper Band$26.71
    Lower Band$14.68
    %B Position5811%(Upper)
    Band Width0.96

    RSI (14-Day)

    Overbought
    73.2

    Momentum Oscillators

    Stoch %K94.8
    Stoch %D95.0
    Williams %R-4.8
    ROC (10d)35.5%
    Momentum6.88
    CCI (20d)162.3
    MFI (14d)82.5

    Volatility Measures

    ATR (14d)$1.73(6.6%)
    StdDev (20d)3.01
    Hist Vol74.0%(High)

    Volume Flow

    VWAP$26.24
    OBV5.0M
    AD Line3.8M
    CMF (20d)0.400

    Volume Metrics

    Avg Vol (20d)269.2K
    Vol Ratio0.7x
    VWMA (20d)$22.63

    Pivot Points

    R3$27.56
    R2$26.93
    R1$26.34
    Pivot Point$25.71
    S1$25.12
    S2$24.49
    S3$23.90

    Advanced Oscillators

    TSI31.21
    Ultimate Osc74.2
    KST181.59

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$46.49M$35.95M$36.56M$23.55M$17.68M$10.49M$10.49M$7.78M$5.94M$6.41M$5.43M$4.88M
    Cost of Revenue$16.29M$12.67M$14.82M$9.53M$10.39M$6.59M$6.59M$3.83M$2.17M$2.63M$2.76M$3.22M
    Gross Profit$30.20M$23.28M$21.74M$14.02M$7.29M$3.90M$3.90M$3.95M$3.77M$3.78M$2.67M$1.65M
    Operating Expenses$52.12M$32.99M$34.13M$20.19M$17.35M$20.47M$28.35M$15.76M$14.38M$12.94M$14.86M$14.60M
    R&D$757,000$1.44M$742,999$1.17M$1.21M$2.58M$2.58M$2.59M$3.03M$2.73M$2.59M$4.00M
    SG&A$0$9.34M$14.62M$9.55M$10.49M$16.78M$19.18M$11.20M$9.69M$9.06M$10.36M$10.56M
    Operating Income$-21,919,000$-9,706,000$-12,391,000$-6,164,000$-10,065,000$-16,567,805$-17,861,421$-11,808,320$-10,608,960$-9,160,000$-12,187,090$-12,943,513
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$13,000$9,000$44,999$55,000$65,000$78,630$78,630$80,552$27,479$16,000$31,610$35,492
    Income Before Tax$-9,083,000$-27,308,000$-28,370,000$-6,779,000$-10,954,000$-24,968,782$-24,968,782$-12,113,174$-11,130,664$-9,311,000$-17,889,556$-11,997,699
    Income Tax Expense$4,999$28,000$42,999$9,000$-33,000$-7,423,521$0$-75,307$89,233$-286,000$10,678$-11,544
    Net Income$-8,983,000$-23,104,000$-28,115,000$-7,408,000$-12,410,000$-16,341,715$-16,341,715$-10,672,236$-10,721,954$-8,568,000$-19,047,124$-13,570,455
    EBITDA$-21,727,000$-9,522,000$-24,543,000$-6,724,000$-10,889,000$-24,890,152N/A$-10,930,560$-10,001,123$-9,295,000$-11,877,280$-11,962,207
    EBIT$-21,919,000$-9,706,000$-28,325,000N/AN/AN/AN/A$-12,032,622$-11,103,185$-11,924,606$-12,187,092$-12,748,548
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PRE

    News

    Prenetics CEO Danny Sheng Wu Yeung reports $373,394 purchase of common shares

    Prenetics CEO Danny Sheng Wu Yeung has reported a purchase of $373,394 worth of common shares, increasing his direct holdings to 112,416 Class A ordinary shares. He also transferred 49,912 Class A ordinary shares and settled restricted stock units into 53,953 Class A ordinary shares. This information is based on an original content published via EDGAR.

    Bitget•8/25/26•
    Bullish

    Prenetics (NASDAQ: PRE) CFO gets RSU shares at $0.0001 and $0.00

    Prenetics Global Ltd's CFO, Hoi Chun Lo, exercised Restricted Stock Units (RSUs) on August 21, 2026, acquiring 32,736 Class A Ordinary Shares at $0.0001 per share and 45,815 shares at $0.00 per share. These RSU settlements are part of the company's 2022 Share Incentive Plan, with some awards adjusted due to a prior 1-for-15 reverse stock split. The vesting of these RSUs and their settlement into shares occur at the CFO's election, in accordance with the company's insider trading policy.

    Stock Titan•8/25/26•
    Neutral

    Prenetics Global (PRE) CEO buys 24,681 shares, transfers 49,912

    Prenetics Global Ltd (PRE) CEO Danny Sheng Wu Yeung engaged in multiple share transactions, including exercising 53,953 Class A Ordinary Shares from Restricted Stock Units (RSUs) and transferring 49,912 shares to an ex-spouse due to a domestic relations order. Additionally, he purchased 24,681 Class A Ordinary Shares in open-market transactions between August 20 and August 24, 2026, at prices ranging from $18.31 to $21.40 per share. These RSUs were granted under the 2022 Share Incentive Plan and were adjusted following a 1-for-15 reverse stock split.

    Stock Titan•8/25/26•
    Somewhat-Bullish

    Prenetics (PRE) hits first positive adjusted free cash flow month

    Prenetics (PRE) has reported its first month of positive consolidated Adjusted Free Cash Flow in July 2026, driven by strong growth in its consumer health business, IM8. The company's Q2 2026 revenue from continuing operations reached $46.5 million, a 3.9x year-over-year increase, and it raised its full-year 2026 revenue guidance to $220-$230 million. This milestone follows securing a $1 billion non-dilutive growth financing facility from General Catalyst, which funds marketing spend based on cohort performance.

    Stock Titan•8/18/26•
    Bullish

    Prenetics Global Ltd (PRE) officer Tat Thuan Yen files Form 3 with no trades

    Tat Thuan Yen, VP, Finance of IM8 (US) LLC, an affiliated entity of Prenetics Global Ltd (PRE), has filed an initial Form 3, which is an insider ownership filing. This filing indicates that Yen is an officer but reports no equity transactions or specific security holdings, and includes a Power of Attorney exhibit. The filing acts as an initial statement of beneficial ownership with no reported buy or sell transactions, maintaining a neutral impact and sentiment according to the analysis.

    Stock Titan•8/12/26•
    Neutral

    Frequently Asked Questions About PRE

    Does PRE pay dividends?
    Prenetics Global Ltd (PRE) does not currently pay a regular dividend.
    What is PRE's market cap?
    Prenetics Global Ltd (PRE) has a market capitalization of $432.24M with a current stock price of $26.25.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In